InSysBio to present at PAGE 2019

events
Conference
June 5, 2019

June 5, 2019

InSysBio announces their participation at PAGE 2019 28th Meeting being held from 11 to 14 June 2019 in Stockholm, Sweden. InSysBio is presenting five posters:

Wednesday, June 12 (9:50-11:15):

  • I-86: “Investigation of dose response behavior of bispecific T-cell engaging antibodies using quantitative systems pharmacology modeling” (view abstract) by Oleg Demin Jr and Dmitry Shchelokov

Wednesday, June 12 (15:10-16:40):

  • II-42: “Quantitative Systems Pharmacology model of key intraneuronal pathways regulating toxic protein accumulation” (view abstract) by Mark Meerson, Tatiana Karelina and Diana Сlausznitzer (Abbvie)

Thursday, June 13 (9:55-11:20):

  • III-16: “Physiologically based pharmacokinetic modeling of anti-PD-1 therapeutic antibodies” (view abstract) by Dmitry Shchelokov and Oleg Demin Jr

Thursday, June 13 (15:25-16:50):

  • IV-74: “Amyloid ? in vitro prion properties and in vivo pathology exacerbation mechanisms studied by translation quantitative systems pharmacology model for prediction of anti-protofibril immunotherapy effects” (view abstract) by Tatiana Karelina

  • V-89: “Application of different approaches to generate virtual patient populations for QSP model of physiologically based pharmacokinetic model of anti-PD-1 therapeutic antibodies” (view abstract) by Galina Kolesova, Oleg Demin, Evgeny Metelkin and Dmitry Shchelokov

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative approach has already become a part of the drug development process implemented by our strategic partners: nowadays there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. The company has published multiple scientific studies in various therapeutic areas. InSysBio team is developing software and tools for QSP and continuously improves methods for biological modeling. For more information about InSysBio, its solutions and services, visit insysbio.com.

July 2021
MoTuWeThFrSaSu
   
1
2
3
4
5
6
7
1. 07 Jul 2021 12:40 InSysBio to present its posters at AAIC 2021 InSysBio announces its participation in AAIC 2021 (Online). Alzheimer's Association International Conference is held in Denver, USA and Online in July 26-30, 2021. InSysBio Neurodegeneration Diseases team presents two posters within its frames
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
1. 22 Jul 2021 16:03 InSysBio to present Immune Response Template v. 3.5.0 Now IRT gets significant update and a portion of new data [Moscow – 22.07.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launches Immune Response Template (IRT) version 3.5.0.
23
24
25
26
27
28
1. 28 Jul 2021 16:26 InSysBio to take part in ESMO Congress 2021 InSysBio announces its participation in ESMO (European Sosiety For Medical Oncology) Virtual Congress 2021 which is held on September 16-21. InSysBio team's abstract was accepted
29
30
31
 
Upcoming Events
Tags
Latest News
10.09
InSysBio team to publish the new article in PSPJournal
04.09
InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling
22.02
14th InSysBio’s Annual Internal Scientific Meeting
24.01
InSysBio to present the new Plugin for Sublime Text and Heta compiler Online
07.12
InSysBio to release public beta of fIVE Calculator